-
effectivehealthcare.ahrq.gov/news/epc-year-in-review-2019
-
effectivehealthcare.ahrq.gov/products/osteoporosis-bone-fracture/research-protocol
-
effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract
-
effectivehealthcare.ahrq.gov/health-topics/cervix-disorders
-
effectivehealthcare.ahrq.gov/health-topics/lymphedema
-
effectivehealthcare.ahrq.gov/health-topics/teen-violence
-
effectivehealthcare.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening
APPENDIX A FDA STATUS- SCREENING DEVICES
SE: Substantially equivalent; Premarket notification, 501(k)
Page 1 of 19
Ophthalmoscope, AC-powered
Product code: HLI
COMPANY PRODUCT FDA STATUS* APPROVAL DATE
ACCUTECH MEDICAL TECHNOLOGIES IN…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening
APPENDIX A FDA STATUS- SCREENING DEVICES
SE: Substantially equivalent; Premarket notification, 501(k)
Page 1 of 19
Ophthalmoscope, AC-powered
Product code: HLI
COMPANY PRODUCT FDA STATUS* APPROVAL DATE
ACCUTECH MEDICAL TECHNOLOGIES IN…
-
effectivehealthcare.ahrq.gov/products/methods-prioritization-harms/methods
-
effectivehealthcare.ahrq.gov/products/renal-disease-anemia/abstract
-
effectivehealthcare.ahrq.gov/products/liver-cancer-therapy/research
-
effectivehealthcare.ahrq.gov/products/strategies-integrating-behavioral-health/protocol
-
effectivehealthcare.ahrq.gov/products/get-involved/synthesizing-evidence-brochure
-
effectivehealthcare.ahrq.gov/products/get-involved/making-sure-brochure
-
effectivehealthcare.ahrq.gov/products/hypertensive-disorders-pregnancy/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - E-1. Can. Study Characteristics
Table E-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - F-1. Can. Study Characteristics
Table F-1. Cannabis RCTs study characteristics
PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…
-
effectivehealthcare.ahrq.gov/health-topics/understanding-medical-research